Ftse Mib
37.239,57
0,50%
DAX
21.911,74
0,68%
S&P 500
6.061,41
0,59%
NASDAQ
19.733,09
1,07%
Bitcoin
97.358,69
0,89%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Rigel Pharmaceuticals Inc (RIGL) Rigel Pharmaceuticals Inc (RIGL) Notizie

Rigel Pharmaceuticals Inc

RIGL
20,965
-0,975 (-4,44%)
Ultimo aggiornamento: 17:39:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/2/202502:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202502:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202502:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202502:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202521:58EDGAR2Form 144 - Report of proposed sale of securities
05/2/202521:43EDGAR2Form 144 - Report of proposed sale of securities
05/2/202521:41EDGAR2Form 144 - Report of proposed sale of securities
05/2/202521:40EDGAR2Form 144 - Report of proposed sale of securities
05/2/202519:23EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
04/2/202522:39EDGAR2Form 144 - Report of proposed sale of securities
04/2/202522:30EDGAR2Form 144 - Report of proposed sale of securities
04/2/202522:21EDGAR2Form 144 - Report of proposed sale of securities
04/2/202522:20EDGAR2Form 144 - Report of proposed sale of securities
01/2/202500:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202500:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202500:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202500:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202502:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202522:38EDGAR2Form 144 - Report of proposed sale of securities
22/1/202514:05PRNUSRigel's Fostamatinib Being Studied by National Institute of..
13/1/202514:15EDGAR2Form 8-K - Current report
13/1/202514:05PRNUSRigel Provides Business Update and 2025 Outlook
09/1/202514:05PRNUSRigel Announces R289 Granted Orphan Drug Designation by the..
08/1/202514:05PRNUSRigel to Present at the 43rd Annual J.P. Morgan Healthcare..
03/1/202514:05PRNUSRigel Pharmaceuticals, Inc. Announces Inducement Grants..
09/12/202422:15EDGAR2Form 8-K - Current report
09/12/202418:02PRNUSRigel Highlights Initial Data from Ongoing Phase 1b Study..
02/12/202414:05PRNUSRigel Announces R289 Granted Fast Track Designation by the..
27/11/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202423:18EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202421:33EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202414:05PRNUSRigel to Present at the Jefferies London Healthcare..
07/11/202422:22EDGAR2Form 8-K - Current report
07/11/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:01PRNUSRigel Reports Third Quarter 2024 Financial Results and..
05/11/202415:05PRNUSRigel Announces Six Poster Presentations at the 66th..
31/10/202413:05PRNUSRigel Announces Conference Call and Webcast to Report Third..
24/10/202422:35PRNUSRigel Pharmaceuticals Issues Dear Healthcare Provider Letter..
16/10/202416:00GLOBEOptime Care Expands Partnership with Rigel Pharmaceuticals..
04/10/202414:05PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
19/9/202422:01EDGAR2Form 8-K - Current report
12/9/202414:05PRNUSRigel to Present at the 2024 Cantor Global Healthcare..
05/9/202413:30PRNUSRigel Announces First Patient Enrolled in Phase 1b/2 Triplet..
05/9/202402:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202402:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202414:30EDGAR2Form 8-K - Current report
03/9/202414:00PRNUSRigel Expands Relationship with Kissei to include REZLIDHIA®..
29/8/202414:05PRNUSRigel to Participate in Upcoming September Investor..
Apertura: 21,95 Min: 20,61 Max: 22,09
Chiusura: 21,94

La tua Cronologia

NASDAQ
RIGL
Rigel Pharmaceuticals
AQSE
SAL.GB
Spaceandpeople
BIT
UC4NJ1
Unicredit Bank
BIT
S31840
Societe Generale Effekten
BIT
EUCO
SSgA SPDR ETFs EUROPE I ...
BOV
TPIS3F
TRIUNFO PART ON
BIT
NSCIT000A2W6
Austria
AQSE
XGSG.GB
Deutsche Bank Luxembourg
BIT
P228M7
NLBNPIT228M7 20991231 18...
BIT
P1KP50
BNP Paribas Issuance
BIT
F25248
Vontobel Financial Produ...
BIT
UB7N7A
Unicredit Bank
BIT
VPN
Global X Data Center Rei...
POLO
GEARUSDT
Gearbox
AQSE
ZGLD.GB
ZKB Gold ETF AA CHF ETF
BIT
I10487
IT0005616278 20250602 21
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci